Logo image of 1ANTM.MI

ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis

BIT:1ANTM - US0367521038 - Common Stock

246 EUR
+5.4 (+2.24%)
Last: 7/25/2025, 7:00:00 PM
Fundamental Rating

5

Overall 1ANTM gets a fundamental rating of 5 out of 10. We evaluated 1ANTM against 28 industry peers in the Health Care Providers & Services industry. 1ANTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1ANTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

1ANTM had positive earnings in the past year.
1ANTM had a positive operating cash flow in the past year.
In the past 5 years 1ANTM has always been profitable.
In the past 5 years 1ANTM always reported a positive cash flow from operatings.
1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCF1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.40%, 1ANTM is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
1ANTM's Return On Equity of 12.26% is fine compared to the rest of the industry. 1ANTM outperforms 70.37% of its industry peers.
With a decent Return On Invested Capital value of 5.90%, 1ANTM is doing good in the industry, outperforming 62.96% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1ANTM is in line with the industry average of 6.48%.
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROIC 5.9%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1ANTM.MI Yearly ROA, ROE, ROIC1ANTM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 2.83%, 1ANTM perfoms like the industry average, outperforming 59.26% of the companies in the same industry.
In the last couple of years the Profit Margin of 1ANTM has declined.
1ANTM's Operating Margin of 4.60% is in line compared to the rest of the industry. 1ANTM outperforms 48.15% of its industry peers.
In the last couple of years the Operating Margin of 1ANTM has declined.
Industry RankSector Rank
OM 4.6%
PM (TTM) 2.83%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
1ANTM.MI Yearly Profit, Operating, Gross Margins1ANTM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

3

2. Health

2.1 Basic Checks

1ANTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for 1ANTM has been reduced compared to 1 year ago.
Compared to 5 years ago, 1ANTM has less shares outstanding
Compared to 1 year ago, 1ANTM has a worse debt to assets ratio.
1ANTM.MI Yearly Shares Outstanding1ANTM.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1ANTM.MI Yearly Total Debt VS Total Assets1ANTM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1ANTM has a debt to FCF ratio of 5.70. This is a neutral value as 1ANTM would need 5.70 years to pay back of all of its debts.
1ANTM has a Debt to FCF ratio of 5.70. This is in the better half of the industry: 1ANTM outperforms 74.07% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that 1ANTM is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, 1ANTM is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Altman-Z N/A
ROIC/WACC0.78
WACC7.59%
1ANTM.MI Yearly LT Debt VS Equity VS FCF1ANTM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
1ANTM.MI Yearly Current Assets VS Current Liabilites1ANTM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

6

3. Growth

3.1 Past

The earnings per share for 1ANTM have decreased by -6.64% in the last year.
The Earnings Per Share has been growing by 11.17% on average over the past years. This is quite good.
1ANTM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.21%.
1ANTM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.14% yearly.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%

3.2 Future

The Earnings Per Share is expected to grow by 12.57% on average over the next years. This is quite good.
1ANTM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.96% yearly.
EPS Next Y5.39%
EPS Next 2Y9.72%
EPS Next 3Y11.61%
EPS Next 5Y12.57%
Revenue Next Year12.17%
Revenue Next 2Y8.92%
Revenue Next 3Y8.04%
Revenue Next 5Y8.96%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1ANTM.MI Yearly Revenue VS Estimates1ANTM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B 250B
1ANTM.MI Yearly EPS VS Estimates1ANTM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.50, which indicates a very decent valuation of 1ANTM.
Compared to the rest of the industry, the Price/Earnings ratio of 1ANTM indicates a rather cheap valuation: 1ANTM is cheaper than 92.59% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.06, 1ANTM is valued rather cheaply.
The Price/Forward Earnings ratio is 7.07, which indicates a rather cheap valuation of 1ANTM.
Based on the Price/Forward Earnings ratio, 1ANTM is valued cheaply inside the industry as 92.59% of the companies are valued more expensively.
1ANTM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.69.
Industry RankSector Rank
PE 8.5
Fwd PE 7.07
1ANTM.MI Price Earnings VS Forward Price Earnings1ANTM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1ANTM.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ANTM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 11.94
EV/EBITDA 8.29
1ANTM.MI Per share data1ANTM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.58
PEG (5Y)0.76
EPS Next 2Y9.72%
EPS Next 3Y11.61%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.42%, 1ANTM has a reasonable but not impressive dividend return.
1ANTM's Dividend Yield is a higher than the industry average which is at 2.70.
Compared to an average S&P500 Dividend Yield of 2.32, 1ANTM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.42%

5.2 History

The dividend of 1ANTM is nicely growing with an annual growth rate of 15.34%!
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

28.40% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
1ANTM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y9.72%
EPS Next 3Y11.61%
1ANTM.MI Yearly Income VS Free CF VS Dividend1ANTM.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
1ANTM.MI Dividend Payout.1ANTM.MI Dividend Payout, showing the Payout Ratio.1ANTM.MI Dividend Payout.PayoutRetained Earnings

ELEVANCE HEALTH INC

BIT:1ANTM (7/25/2025, 7:00:00 PM)

246

+5.4 (+2.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)10-15 2025-10-15/amc
Inst Owners92.69%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap55.39B
Analysts79.29
Price Target419.89 (70.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.42%
Yearly Dividend5.74
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)-13.09%
PT rev (3m)-13.09%
EPS NQ rev (1m)-42.57%
EPS NQ rev (3m)-42.57%
EPS NY rev (1m)0.54%
EPS NY rev (3m)0.54%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)0.5%
Revenue NY rev (1m)1.8%
Revenue NY rev (3m)1.8%
Valuation
Industry RankSector Rank
PE 8.5
Fwd PE 7.07
P/S 0.33
P/FCF 11.94
P/OCF 9.86
P/B 1.44
P/tB 16.35
EV/EBITDA 8.29
EPS(TTM)28.95
EY11.77%
EPS(NY)34.8
Fwd EY14.15%
FCF(TTM)20.61
FCFY8.38%
OCF(TTM)24.96
OCFY10.15%
SpS736.98
BVpS170.26
TBVpS15.05
PEG (NY)1.58
PEG (5Y)0.76
Profitability
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROCE 7.72%
ROIC 5.9%
ROICexc 6.38%
ROICexgc 11.77%
OM 4.6%
PM (TTM) 2.83%
GM N/A
FCFM 2.8%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexcg growth 3Y-5.49%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Debt/EBITDA 2.8
Cap/Depr 75.47%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 62.96%
Profit Quality 98.73%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.59%
ROIC/WACC0.78
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y5.39%
EPS Next 2Y9.72%
EPS Next 3Y11.61%
EPS Next 5Y12.57%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
Revenue Next Year12.17%
Revenue Next 2Y8.92%
Revenue Next 3Y8.04%
Revenue Next 5Y8.96%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year11.18%
EBIT Next 3Y10.33%
EBIT Next 5Y11.33%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%